Immune responses are elicited through antigen presentation and recognition by macrophages and T-lymphocytes, respectively. The immunomodulatory effect of vitamin D3 on macrophage phagocytic potential with live Mycobacterium tuberculosis, spontaneous and M. tuberculosis culture filtrate antigen induced lymphocyte responses were studied in pulmonary tuberculosis patients (PTBPs) (n = 31) and normal healthy subjects (NHSs) (n = 43). Vitamin D3 at a concentration of 10−7 M significantly enhanced the macrophage phagocytosis of live M. tuberculosis in normal subjects with low phagocytic potential (less than 10%) (p = 0.015). No such increase was observed in PTBPs. Vitamin D3 significantly decreased the spontaneous lymphoproliferative response (p = 0.022) and increased the apoptosis of peripheral blood mononuclear cells in PTBPs (p = 0.024). In normals, vitamin D3 increased the spontaneous lymphoproliferative response. An inverse correlation between macrophage phagocytosis and spontaneous response was observed in NHSs, whereas a direct correlation was seen between vitamin D3-treated cells in normal subjects under in vitro condition. Vitamin D3 decreased the M. tuberculosis culture filtrate antigen induced lymphocyte response significantly in normal subjects (p = 0.0003), while it had no influence on the lymphocyte response in PTBPs. The present study suggests that exposure to vitamin D3 increases the phagocytic potential and spontaneous lymphoproliferative response but brings down the antigen-induced response in normals. In tuberculosis, addition of vitamin D3 has no significant effect on antigen-induced lymphoproliferative response. This may be due to the unresponsive nature of the cells to the action of vitamin D3 by virtue of the disease, which renders them inactive.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Kaufmann SH: Protection against tuberculosis: Cytokines, T cells, and macrophages. Ann Rheum Dis 61(Suppl 2:ii):54-58, 2002
Dowling GB, Prosser-Thomas EW: Treatment of lupus vulgaris with calciferol. Lancet 1:919-922, 1946
Sharma OP: Hypercalcemia in granulomatous disorders: A clinical review. Curr Opin Pulm Med 6:442-447, 2000
Sharma SC: Serum calcium in pulmonary tuberculosis. Postgrad Med J 57:694-696, 1981
Davies PD, Brown RC, Church HA, Woodhead JS: The effect of anti-tuberculosis chemotherapy on vitamin D and calcium metabolism. Tubercle 68:261-266, 1987
Chan TY, Poon P, Pang J, Swaminathan R, Chan CH, Nisar M, Williams CS, Davies PD: A study of the calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. J Trop Med Hyg 97:26-30, 1994
Liam CK, Lim KH, Srinivas P, Poi PJ: Hypercalcaemia in patients with newly diagnosed tuberculosis in Malaysia. Int J Tuberc Lung Dis 2:818-823, 1998
Roussos A, Lagogianni I, Gonis A, Ilias I, Kazi D, Patsopoulos D, Philippou N: Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment. Respir Med 95:187-190, 2001
Abbasi AA, Chemplavil JK, Farah S, Muller BF, Arnstein AR: Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med 90:324-328, 1979
Need AG, Phillips PJ, Chiu FTS, Prisk HM: Hypercalcaemia associated with tuberculosis. BMJ 280:831, 1980
Chan TY, Chan CH, Shek CC: The prevalence of hypercalcaemia in pulmonary and miliary tuberculosis—a longtitudinal study. Singapore Med J 35:613-615, 1994
Davies PD, Church HA, Brown RC, Woodhead JS: Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 71:341-344, 1987
Chan TY, Chan CH, Shek CC, Davies PD: Hypercalcemia in active pulmonary tuberculosis and its occurrence in relation to the radiographic extent of disease. Southeast Asian J Trop Med Public Health 23:702-704, 1992
Reichel H, Koeffler HP, Barbers R, Norman AW: Regulation of 1,25-dihydroxyvitamin D3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 65:1201-1209, 1987
Cadranel J, Hance AJ, Milleron B, Paillard F, Akown GM, Garabedian M: Vitamin D metabolism in tuberculosis: Production of 1,25 (OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis. Am Rev Respir Dis 138:984-989, 1988
Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ: 1,25 (OH)2D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemie patients with tuberculosis. J Clin Invest 85:1588-1593, 1990
Lemire JM: Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 53:599-602, 1995
Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, Stanford J: Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159-163, 1986
Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V: Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164:4443-4451, 2000
D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P: Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252-262, 1998
Penna G, Adorini L: 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405-2411, 2000
Muller K, Odum N, Bendtzen K: 1,25-Dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro. Immunol Lett 35:177-182, 1993
Malloy PJ, Feldman D: Vitamin D resistance. Am J Med 106:355-370, 1999
Zabaleta J, Arias M, Maya JR, Garcia LF: Diminished adherence and/or ingestion of virulent Mycobacterium tuberculosis by monocyte-derived macrophages from patients with tuberculosis. Clin Diagn Lab Immunol 5:690-694, 1998
Selvaraj P, Kurian SM, Uma H, Reetha AM, Narayanan PR: Influence of non-MHC genes on lymphocyte response to Mycobacterium tuberculosis antigens &; tuberculin reactive status in pulmonary tuberculosis. Indian J Med Res 112:86-92, 2000
Placido R, Mancino G, Amendola A, Mariani F, Vendetti S, Piacentini M, Sanduzzi A, Bocchino ML, Zembala M, Colizzi V: Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol 181:31-38, 1997
Barnes PF, Chatterjee D, Abrams JS, Lu S, Wang E, Yamamura M, Brennan PJ, Modlin RL: Cytokine production induced by Mycobacterium tuberculosis lipo-arabinomannan. Relationship to chemical structure. J Immunol 149:541-547, 1992
Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF: Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 64:1351-1356, 1996
Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153:811-816, 1994
Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ: Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol 154:465-473, 1995
Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z: Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis 170:1229-1237, 1994
Tsoukas CD, Provvedini DM, Manolagas SC: 1,25-Dihydroxyvitamin D3: A novel immunoregulatory hormone. Science 224:1438-1440, 1984
Lemire JM, Adams JS, Sakai R, Jordan SC: 1 Alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74:657-661, 1984
Casteels K, Bouillon R, Waer M, Mathieu C: Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr Opin Nephrol Hypertens 4:313-318, 1995
Rigby WF, Waugh M, Graziano RF: Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihydroxyvitamin D3. Blood 76:189-197, 1990
Rook GAW: The role of vitamin D in tuberculosis. Am Rev Respir Dis 138:768-770, 1988
About this article
Cite this article
Chandra, G., Selvaraj, P., Jawahar, M.S. et al. Effect of Vitamin D3 on Phagocytic Potential of Macrophages with Live Mycobacterium tuberculosis and Lymphoproliferative Response in Pulmonary Tuberculosis. J Clin Immunol 24, 249–257 (2004). https://doi.org/10.1023/B:JOCI.0000025446.44146.52
- Vit. D3
- M. tuberculosis
- pulmonary TB.